Crossmark

Advances and challenges in kidney fibrosis therapeutics

Crossref DOI link: https://doi.org/10.1038/s41581-025-00934-5

Published Online: 2025-02-11

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abbad, Lilia https://orcid.org/0000-0001-6548-6935
Esteve, Emmanuel https://orcid.org/0000-0003-3656-8557
Chatziantoniou, Christos https://orcid.org/0000-0003-4440-099X
License Information

Text and Data Mining valid from 2025-02-11

Version of Record valid from 2025-02-11
More Information

Article History

Accepted: 20 January 2025

First Online: 11 February 2025

Competing interests

: The authors declare no competing interests.